MERLITA GUERRERO: Open Payments
NPI 1346012416 · BAYVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 22 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $449 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $278 |
| Corcept Therapeutics | 4 | $148 |
| ABBVIE INC. | 6 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Verona Pharma, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: AIRSUPRA, Korlym, VRAYLAR, REXULTI, UBRELVY, Ohtuvayre, CLOSUREFAST, Kerendia.
Industry payments across NJ — which companies pay providers there.
